MMSI Quote, Financials, Valuation and Earnings

Globus Medical, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 15.47%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Globus Medical, Inc.'s return on equity of 10.08%.

Merit Medical Systems, Inc. has a consensus price target of $103.64, signalling upside risk potential of 26.63%. On the other hand Globus Medical, Inc. has an analysts' consensus of $107.17 which suggests that it could grow by 17.87%. Given that Merit Medical Systems, Inc. has higher upside potential than Globus Medical, Inc., analysts believe Merit Medical Systems, Inc. is more attractive than Globus Medical, Inc..

Merit Medical Systems, Inc. has a beta of 0.612, which suggesting that the stock is 38.827% less volatile than S&P 500. In comparison Globus Medical, Inc. has a beta of 1.056, suggesting its more volatile than the S&P 500 by 5.621%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Globus Medical, Inc. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Globus Medical, Inc. quarterly revenues of $769M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Globus Medical, Inc.'s net income of $119M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.89x while Globus Medical, Inc.'s PE ratio is 29.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.36x versus 4.52x for Globus Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Masimo Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 14.46%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Masimo Corp.'s return on equity of -19.18%.

Merit Medical Systems, Inc. has a consensus price target of $103.64, signalling upside risk potential of 26.63%. On the other hand Masimo Corp. has an analysts' consensus of $178.60 which suggests that it could grow by 1.87%. Given that Merit Medical Systems, Inc. has higher upside potential than Masimo Corp., analysts believe Merit Medical Systems, Inc. is more attractive than Masimo Corp..

Merit Medical Systems, Inc. has a beta of 0.612, which suggesting that the stock is 38.827% less volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.165%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are larger than Masimo Corp. quarterly revenues of $371.5M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Masimo Corp.'s net income of $53.7M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.89x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.36x versus 5.54x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 12.96%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Insulet Corp.'s return on equity of 17.89%.

Merit Medical Systems, Inc. has a consensus price target of $103.64, signalling upside risk potential of 26.63%. On the other hand Insulet Corp. has an analysts' consensus of $357.00 which suggests that it could grow by 43.32%. Given that Insulet Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Insulet Corp. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.612, which suggesting that the stock is 38.827% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.412, suggesting its more volatile than the S&P 500 by 41.175%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Insulet Corp. quarterly revenues of $783.8M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Insulet Corp.'s net income of $101.6M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.89x while Insulet Corp.'s PE ratio is 71.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.36x versus 6.58x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Stryker Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 11.84%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Stryker Corp.'s return on equity of 15.17%.

Merit Medical Systems, Inc. has a consensus price target of $103.64, signalling upside risk potential of 26.63%. On the other hand Stryker Corp. has an analysts' consensus of $424.40 which suggests that it could grow by 13.88%. Given that Merit Medical Systems, Inc. has higher upside potential than Stryker Corp., analysts believe Merit Medical Systems, Inc. is more attractive than Stryker Corp..

Merit Medical Systems, Inc. has a beta of 0.612, which suggesting that the stock is 38.827% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.679%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker Corp. offers a yield of 0.91% to investors and pays a quarterly dividend of $0.88 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Stryker Corp. pays out 40.48% of its earnings as a dividend. Stryker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Stryker Corp. quarterly revenues of $7.2B. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Stryker Corp.'s net income of $849M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.89x while Stryker Corp.'s PE ratio is 44.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.36x versus 5.73x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.